|
Market Closed -
NSE India S.E.
06:05:07 2026-11-12 EST
|
5-day change | 1st Jan Change | ||
| 2,659.80 INR | -0.65% |
|
+6.19% | +30.69% |
| 11-09 | Acucort signs exclusive agreement for Zeqmelit in Canada - launch expected in 2028 | FW |
| 11-06 | Glenmark Pharmaceuticals Limited, Q2 2027 Earnings Call, Nov 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 8.06B | |||||
| 1,280B | |||||
| 675B | |||||
| 521B | |||||
| 386B | |||||
| 363B |
Select your edition
All financial news and data tailored to specific country editions
